Skip to Content

Dealflow: Funding of Innovative Startups

Osiris Therapeutics, Miasole, PicoChip, and more
September 1, 2005

Company Spotlight
Miasol
  Several solar startups with innovative new technologies, including Nanosolar and Konarka, have recently received venture-capital funding. Miasolis looking to make solar power cost-effective by using thin-film manufacturing techniques, avoiding the expensive processing that silicon-based solar cells require.

Miasol enjoys great buzz thanks to a $16 million investment from the superstar VC firm Kleiner, Perkins. However, its competitor Nanosolar has also recently raised $20 million. It remains to be seen whether these new types of solar cells are generating investments based on the general promise of cleaner energy or whether they are commercially feasible technologies able to compete with existing and well-entrenched silicon-based photovoltaics.

Osiris Therapeutics  Amid all the debate over embryonic-stem-cell research, Osiris Therapeutics has been advancing the development of adult-stem-cell therapies. By using stem cells extracted from the bone marrow of living adults, Osiris has dodged the criticism that it is unethical to harvest cells from embryos.

Some Osiris products are already undergoing human tests. The first treatment for bone marrow transplant complications in leukemia patients is in phase II clinical trials and is the only stem-cell product with U.S. Food and Drug Administration fast-track status, according to Osiris. Two other products are also ready for human trials. One, designed to heal heart muscle damage in heart-attack patients, is in phase I clinical trials, and another, which will help repair knee tissue, recently won FDA approval to begin clinical trials.

While it is generally accepted by scientists that embryonic stem cells will have broader therapeutic applications, adult stem cells could also play a valuable role in repairing some types of tissue, and Osiris’s approach seems to be working. The company believes that, if all goes according to plan, its first therapeutic product may be available by 2007. 

Keep Reading

Most Popular

conceptual illustration of a heart with an arrow going in on one side and a cursor coming out on the other
conceptual illustration of a heart with an arrow going in on one side and a cursor coming out on the other

Forget dating apps: Here’s how the net’s newest matchmakers help you find love

Fed up with apps, people looking for romance are finding inspiration on Twitter, TikTok—and even email newsletters.

computation concept
computation concept

How AI is reinventing what computers are

Three key ways artificial intelligence is changing what it means to compute.

still from Embodied Intelligence video
still from Embodied Intelligence video

These weird virtual creatures evolve their bodies to solve problems

They show how intelligence and body plans are closely linked—and could unlock AI for robots.

We reviewed three at-home covid tests. The results were mixed.

Over-the-counter coronavirus tests are finally available in the US. Some are more accurate and easier to use than others.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.